Pandion Therapeutics Inc. (PAND): Price and Financial Metrics
PAND Price/Volume Stats
| Current price | $60.05 | 52-week high | $62.90 |
| Prev. close | $59.92 | 52-week low | $10.28 |
| Day low | $59.95 | Volume | 241,500 |
| Day high | $60.05 | Avg. volume | 355,921 |
| 50-day MA | $40.01 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.77B |
PAND Stock Price Chart Interactive Chart >
Pandion Therapeutics Inc. (PAND) Company Bio
Pandion Therapeutics, Inc. is clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. The firm develops Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. TALON platform employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded on December 31, 2018 and is headquartered in Watertown, MA.
PAND Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...